Landmark Vertex cystic fibrosis drug could hit market by late 2019: analyst
February 22, 2018 at 11:19 AM EST
The Boston-based company said Wednesday that the FDA would allow it to conduct a faster-than-expected study of the “triple combination” treatment.
